Yüklüyor......
Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
Currently, four non-vitamin K antagonists oral anticoagulants (NOACs) are available for stroke prevention in atrial fibrillation (AF). These have been in clinical use for up to 10 years now. Besides data of the initial phase III clinical trials, now clinical data, several sub-studies, meta-analyses,...
Kaydedildi:
| Yayımlandı: | Eur Heart J Suppl |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753780/ https://ncbi.nlm.nih.gov/pubmed/33380942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa177 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|